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A Protocol for a Systematic Review and Meta-Analysis of Efficacy of
Infectious Bovine Keratoconjunctivitis and assessment of
comprehensiveness of reporting
Abstract
Infectious bovine keratoconjunctivitis, commonly known as pinkeye, limits production and weight gain in
pre-weaned calves, resulting in significant economic loss each year. IBK is one of the most common diseases in
pre-weaned calves which leads to clinical signs from mild conjunctivitis to severe ulceration, corneal
perforation, and blindness [4]. Due to large economic losses and limits in production and weaning weight, use
of effective vaccines to prevent IBK is imperative.
Moraxella bovis is the primary causal organism of IBK [4, 5]. However, available evidence does not suggest
that vaccination is effective for preventing naturally occurring IBK. Although individual studies and a prior
review conducted over a decade ago [4, 6, 7] suggested that autogenous and commercial IBK vaccines are not
effective, a systematic review of vaccine efficacy has not been conducted recently. Further, the review
conducted by Burns and O'Connor (7), was conducted using an approach not consistent with current
systematic review quality standards, therefore it is of interest to know if the results of that review are
repeatable. In particular, that review found strong evidence of small study effects, and an association failure to
report randomization and blinded outcome assessment and vaccine effect size. However, the study did not
evaluate the effect of challenge studies, another cause of small study effects The AMSTAR standards [8] is a
frequently used metric for assessing the quality of systematic reviews and the Burns and O'Connor (7) review,
of which one of us was the lead author, fails to meet many of those standards.
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PRISMA-P ITEM 1 Title 
A Protocol for a Systematic Review and Meta-Analysis of Efficacy of Infectious Bovine 
Keratoconjunctivitis and assessment of comprehensiveness of reporting 
PRISMA-P ITEM 2 Registration 
This protocol will be archived in the Iowa State University Digital Institutional Repository and 
published online with Systematic Reviews for Animals and Food (SYREAF) available 
at:  http://www.syreaf.org/. The systematic review will be reported using the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines [1]  This protocol 
is reporting using the items (headings) recommended [2, 3]. 
PRISMA-P ITEM 3 Authors 
Olivia Weaver1, ocweaver@iastate.edu; Ella Meyer1, ellalmey@iastate.edu; Binh Doan1, 
btdoan@iastate.edu; Jan Sargeant2, sargeanj@uoguelph.ca; Annette M. O’Connor1, 
oconnor@iastate.edu,  
1College of Veterinary Medicine, Iowa State University, Ames, IA, USA 
2Center for Public Health and Zoonoses, University of Guelph, Guelph, ON, Canada 
2Department of Population Medicine, Ontario Veterinary College, University of Guelph, 
Guelph, ON, Canada 
Contributions 
O. Weaver drafted the protocol.  All authors helped develop the selection criteria, the risk of bias 
assessment strategy and data extraction criteria. O. Weaver developed the search strategy. A.M 
O’Connor provided statistical expertise. A.M O’Connor provided expertise on infectious bovine 
keratoconjunctivitis. All authors read, provided feedback and approved the final manuscript. 
PRISMA-P ITEM 4 Amendments 
N/A 
PRISMA-P ITEM 5 Support 
This systematic review and meta-analysis, including the development of the protocol, was not 
supported by any external funding. 
Introduction 
PRISMA-P ITEM 6 Rationale 
Infectious bovine keratoconjunctivitis, commonly known as pinkeye, limits production and weight 
gain in pre-weaned calves, resulting in significant economic loss each year. IBK is one of the most 
common diseases in pre-weaned calves which leads to clinical signs from mild conjunctivitis to 
severe ulceration, corneal perforation, and blindness [4]. Due to large economic losses and limits in 
production and weaning weight, use of effective vaccines to prevent IBK is imperative.  
Moraxella bovis is the primary causal organism of IBK [4, 5]. However, available evidence does not 
suggest that vaccination is effective for preventing naturally occurring IBK. Although individual 
studies and a prior review conducted over a decade ago [4, 6, 7] suggested that autogenous and 
commercial IBK vaccines are not effective, a systematic review of vaccine efficacy has not been 
conducted recently. Further, the review conducted by Burns and O'Connor (7), was conducted using 
an approach not consistent with current systematic review quality standards, therefore it is of interest 
to know if the results of that review are repeatable. In particular, that review found strong evidence of 
small study effects, and an association failure to report randomization and blinded outcome 
assessment and vaccine effect size. However, the study did not evaluate the effect of challenge 
studies, another cause of small study effects The AMSTAR standards [8] is a frequently used metric 
for assessing the quality of systematic reviews and the Burns and O'Connor (7) review, of which one 
of us was the lead author, fails to meet many of those standards.  
PRISMA-P ITEM 7 Objectives 
The primary purpose of this review is to summarize the efficacy of IBK vaccines using current 
approaches to research synthesis [9].  The secondary outcome, we will seek to assess the impact of 
sources of heterogeneity on the effect size. The methodological sources of heterogeneity of interest 
are: failure to randomize to treatment group, and blind outcome assessment, are associated with the 
effect size. The contextual sources of heterogeneity are the vaccine type: autogenous (farm specific 
vaccine), experimental, commercially available (has a “brand name”).  The third outcome is to assess 
if reporting of the IBK vaccine trials had improved since the publication of the Burns review [7].  
Methods 
PRISMA-P ITEM 8 Eligibility criteria 
Population: The eligible population consists of beef and dairy calves less than one year old at risk of 
developing naturally occurring IBK or experimentally induced IBK. Studies of vaccine efficacy in 
adult cattle will be excluded. The country of IBK occurrence will not be used as an exclusion factor.  
Interventions and comparator: Eligible interventions and comparators include any vaccination that is 
not banned for use in cattle and non-active placebos. The review is not specifically limited to products 
registered for prevention of IBK.  
Outcome: The primary outcome of interest is the number of cattle with IBK compared to the 
unvaccinated. This is a binary outcome. If investigators use an ordinal score this will be converted to 
a binary outcome: IBK or no IBK based on the description provided by the investigators.   
Study designs: Eligible studies consist of trials where the investigator had the opportunity to 
randomize animals to group. The comparison must occur concurrently. Studies will not be limited by 
publication year and studies published in languages other than English will be noted but not included. 
PRISMA-P ITEM 9 Information sources 
All available years will be searched in MEDLINE through Web of Science and the Center for 
Biosciences and Agriculture International (CABI) databases. Reference lists of relevant manuscripts 
and the table of contents from the last 20 years of the proceedings of the American Association of 
Bovine Practitioners (AABP) and World Buiatrics Association will be reviewed. Recent review 
manuscripts of IBK will be examined for additional reports potentially missed by our database search. 
PRISMA-P ITEM 10 Search strategy 
The goal of the search is to find all relevant studies that would give information to support our 
research question. Therefore, the database search strategy included "population" AND "intervention" 
AND "outcome". The proposed search strategy for CABI is listed in Table 1.  
PRISMA-P ITEM 11 Study records 
Data management 
The de-duplicated search results from EndNote will be uploaded into online systematic review 
software (DistillerSR®, Ottawa, ON, Canada). Reviewers will have training in epidemiology and in 
systematic review methods.  Prior to both abstract and full-text screenings, data extraction, and risk of 
bias assessment, the reviewers assigned to each step will undergo training to ensure consistent data 
collection using the forms created in DistillerSR®.  
 Selection process 
In the first round of screening, two reviewers will independently screen abstracts and titles obtained 
from the search. The reviewers evaluate each citation for relevance using the following questions: 
1) Does the title or abstract indicate primary research?  
a) Yes- next question 
b) No- exclude 
2) Does the title or abstract describe a trial (field or challenge) for vaccine efficacy in IBK or 
pinkeye in cattle? 
a) Yes- next level for full text assessment 
b) No- exclude 
Citations will be excluded if both reviewers responded “no” to either of the questions. Full 
manuscripts will be acquired if one reviewer identifies the title and/or abstract potentially relevant. 
The citations will be further assessed for relevance using the following questions: 
1) Is the full text available in English? 
a) If no, please indicate the language  
2) Correct Population: Does the study population have naturally occurring or experimentally 
included IBK or pinkeye? 
a) Yes- next question 
b) No- exclude 
3) Correct Population: Is the study population composed of healthy beef or dairy cattle likely to be 
younger than one year of age (no immune compromised disease models)? 
a) Yes- next question 
b) No- exclude 
4) Does the study assess a vaccine for preventing IBK? 
a) Yes- next question 
b) No- exclude 
5) Does the study have a concurrent comparison group? 
a) Yes- next question 
b) No- exclude 
6) Does the study report the incidence (risk/proportion) of cases of IBK in both the intervention and 
control groups or a score that could be converted to a proportion? 
a) Yes- study eligible for data extraction 
b) No- exclude 
Data collection process 
Data extraction will be done independently by two reviewers using DistillerSR. The data extraction 
process will be piloted and refined to extract and confirm relevant information is obtained in one 
phase rather than re-visiting each paper multiple times. This process will increase validity and 
efficiency. 
PRISMA-P ITEM 12 Data items 
Study level data collected 
• Country 
• Location 
• Year of conduct 
• Breed 
• Age (entire group or control group data if provided) 
• Weight (entire group or control group data if provided) 
• Definition of IBK provided by the investigators 
• Number of animals eligible for study 
• Approach to allocation 
• Duration of observations for IBK 
• Approach to allocation used by the researchers 
o Random 
o Systematic allocation 
o Other 
o Not described 
Arm level data collected 
• Vaccine name – as listed by investigators 
• Target organism(s) 
• Type of vaccine – autogenous (commercially made), commercial registered, experimental 
• Dose/ Route/ Frequency of administration 
• Timing of vaccination compared to arrival 
• Number of animals enrolled in the group 
• Number of animals lost to follow up 
PRISMA-P ITEM 13 Outcomes and prioritization 
The primary outcome of interest is the risk of IBK, more specifically, the proportion of cattle 
diagnosed with pink eye that received the vaccine compared to those with pink eye but without the 
vaccine. For the primary outcome of interest, risk of IBK, we will extract in the following order of 
possible metrics 
• Adjusted summary effect size (RR or OR) and variables included in adjustment 
• Unadjusted summary effect size summary measures  
• Arm level risk of BRDC 
PRISMA-P ITEM 14 Risk of bias in individual studies 
The risk of bias (ROB - https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool) assessment 
tools proposed by Cochrane ROB 2 will be used for individual trials.  
PRISMA-P ITEM 15 Data synthesis 
As the vaccine antigens are varied it is not reasonable to expect that all are measuring the same thing, 
therefore, we will conduct a pairwise analysis on the following sub groups 1) An autogenous vaccine 
intended for use on farm to prevent IBK (perhaps made by a company or described by the investigator 
as such) compared to no vaccines, 2) commercially available M. bovis vaccine compared to no 
vaccines 3) commercially available M. bovoculi vaccines compared to no vaccines. We will assess 
heterogeneity using standard methods for pairwise meta-analysis and subgroups of interest will be 
randomized allocation or blinded outcome assessment.  
The 2nd analysis will look at the association between the three design elements, (randomized 
allocation or blinded outcome assessment and challenge study) and estimate of vaccine effect for all 
studies – autogenous, commercial and experimental vaccine. The 2nd analysis will also look at the 
association between the 5 ROB domains and estimate of vaccine effect, again for all studies - 
autogenous, commercial and experimental vaccine.  We will assess the association between 
magnitude of comprehensive reported and vaccine effect.  
PRISMA-P ITEM 16 Meta-bias(es) 
Factors associated with small study effects (“publication bias”) will be assessed for all vaccine-
comparator combinations regardless of type of vaccines. The goal here is to evaluate if the association 
between effect size and study size reported by Burns and O'Connor (7) was robust, further we will 
evaluate if the type of study design (challenge, autogenous, and commercial) was associated with 
small study effects.   
PRISMA-P ITEM 17 Confidence in cumulative evidence 
We will interpret the results of the pairwise meta-analysis based on standard interpretation. We will 
assess the impact of bias, reporting and design elements on the effect size using standard 
interpretation.   
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Table 1: Literature review search terms for the Centre for Biosciences and Agriculture International 
(CABI) databases. 
Population Hits 
TS=(cow, OR cows, OR cattle, OR calves, 
OR calf, OR heifer*, OR steer, OR steers, 
OR bull, OR bulls, OR youngstock*, OR 
“young-stock”, OR bovine, OR beef, OR 
dairy, OR bovinae, OR buiatric*) 
639,313 
Intervention   
TS=(vaccin*, OR immuniz*, OR immunis*, 
OR innoculat*) 
371,156 
Outcome  
TS=(“kerato-conjunctivitis”, OR 
conjunctivitis, OR keratoconjunctivitis, OR 
IBK, OR pinkeye, OR ‘pink eye’, OR pink-
eye OR Moraxella OR “New Forest eye”) 
 
14,645 
Population AND Intervention AND Outcome  
#1 AND #2 AND #3 109 
 
